Minerva Neurosciences (NERV) Total Current Liabilities (2013 - 2026)

Minerva Neurosciences' Total Current Liabilities history runs 14 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• Quarterly Total Current Liabilities rose 130.19% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 130.19% YoY) and the FY2025 annual result came in at $2.3 million, down 19.26% from the prior year.
• Total Current Liabilities was $4.5 million for Q1 2026 at Minerva Neurosciences, up from $2.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $4.5 million in Q3 2024 and bottomed at $1.4 million in Q4 2022.
• A 5-year average of $2.9 million and a median of $2.8 million in 2024 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities slumped 51.13% — and 2023, when it surged 142.49%.
• Minerva Neurosciences' Total Current Liabilities stood at $1.4 million in 2022, then surged by 142.49% to $3.3 million in 2023, then dropped by 15.08% to $2.8 million in 2024, then declined by 19.26% to $2.3 million in 2025, then surged by 95.69% to $4.5 million in 2026.
• Business Quant data shows NERV's Total Current Liabilities at $4.5 million in Q1 2026, $2.3 million in Q4 2025, and $2.7 million in Q3 2025.